Gastric Cancer Management and Outcomes
Most cited papers
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience · 1987 · 11,862 citations
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine · 2001 · 11,674 citations
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience · 1989 · 6,856 citations
- Comprehensive molecular characterization of gastric adenocarcinomaNature · 2014 · 6,638 citations
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine · 2006 · 6,411 citations
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine · 2012 · 5,591 citations
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerNew England Journal of Medicine · 2005 · 5,438 citations
- Classification and Grading of GastritisThe American Journal of Surgical Pathology · 1996 · 5,217 citations
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine · 2005 · 5,157 citations
- Helicobacter pylori Infection and the Development of Gastric CancerNew England Journal of Medicine · 2001 · 4,500 citations
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology · 2006 · 4,428 citations
- The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric CancerCellular Physiology and Biochemistry · 2017 · 4,090 citations
Metadata from OpenAlex (CC0).